Christopher Kobylecki

2.3k total citations
65 papers, 1.0k citations indexed

About

Christopher Kobylecki is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Christopher Kobylecki has authored 65 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Neurology, 16 papers in Cellular and Molecular Neuroscience and 15 papers in Psychiatry and Mental health. Recurrent topics in Christopher Kobylecki's work include Parkinson's Disease Mechanisms and Treatments (29 papers), Neurological disorders and treatments (29 papers) and Botulinum Toxin and Related Neurological Disorders (13 papers). Christopher Kobylecki is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (29 papers), Neurological disorders and treatments (29 papers) and Botulinum Toxin and Related Neurological Disorders (13 papers). Christopher Kobylecki collaborates with scholars based in United Kingdom, Qatar and Germany. Christopher Kobylecki's co-authors include Monty Silverdale, Alan R. Crossman, Paula Ravenscroft, Lewis Kass‐Iliyya, Julie S. Snowden, Matthew Jones, Anna Richardson, J. C. Thompson, Rayaz A. Malik and David Neary and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

Christopher Kobylecki

58 papers receiving 998 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Christopher Kobylecki 563 284 213 175 121 65 1.0k
Alexander Pantelyat 612 1.1× 214 0.8× 172 0.8× 147 0.8× 142 1.2× 75 970
Maria Pia Giannoccaro 838 1.5× 293 1.0× 288 1.4× 182 1.0× 115 1.0× 55 1.4k
Antonella Macerollo 839 1.5× 323 1.1× 109 0.5× 234 1.3× 296 2.4× 75 1.4k
Virginia Gao 370 0.7× 378 1.3× 203 1.0× 122 0.7× 103 0.9× 18 1.1k
Cesa Scaglione 1.2k 2.1× 357 1.3× 193 0.9× 173 1.0× 67 0.6× 55 1.5k
Luisa Sambati 595 1.1× 229 0.8× 373 1.8× 258 1.5× 270 2.2× 66 1.4k
Alex Incensi 1.3k 2.2× 294 1.0× 336 1.6× 112 0.6× 135 1.1× 47 1.6k
Daniel Bittner 531 0.9× 113 0.4× 372 1.7× 233 1.3× 310 2.6× 39 1.2k
Davide Martino 869 1.5× 193 0.7× 175 0.8× 158 0.9× 107 0.9× 19 1.1k
Karin Srulijes 882 1.6× 182 0.6× 390 1.8× 129 0.7× 135 1.1× 27 1.3k

Countries citing papers authored by Christopher Kobylecki

Since Specialization
Citations

This map shows the geographic impact of Christopher Kobylecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Kobylecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Kobylecki more than expected).

Fields of papers citing papers by Christopher Kobylecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Kobylecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Kobylecki. The network helps show where Christopher Kobylecki may publish in the future.

Co-authorship network of co-authors of Christopher Kobylecki

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Kobylecki. A scholar is included among the top collaborators of Christopher Kobylecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Kobylecki. Christopher Kobylecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rowe, James B., Tanja Zerenner, Alistair Church, et al.. (2025). Cognitive and neuropsychiatric profiles distinguish atypical parkinsonian syndromes. Brain. 148(9). 3239–3251.
2.
Thomas, Sue, et al.. (2024). Parkinson’s Nurses Are Crucial for the Management of Parkinson’s Disease: 2007–2024. Journal of Parkinson s Disease. 14(s1). S209–S217. 2 indexed citations
3.
Kobylecki, Christopher, Viorica Chelban, Yee Yen Goh, et al.. (2024). Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism. European Journal of Neurology. 31(6). e16258–e16258. 1 indexed citations
4.
Scotton, William J., et al.. (2024). Pick's Disease Presenting as Tremulous Parkinsonism with Limited Levodopa Response—A Rare Cause of Corticobasal Syndrome. Movement Disorders Clinical Practice. 11(8). 1025–1029. 1 indexed citations
5.
Kübler, Dorothee, Christopher Kobylecki, Kathryn McDonald, et al.. (2023). Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease. Parkinsonism & Related Disorders. 107. 105277–105277. 7 indexed citations
6.
Kobylecki, Christopher. (2023). Ataxia and hyperkinetic movement disorders. Medicine. 51(9). 652–657.
7.
Kobylecki, Christopher, et al.. (2023). Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice. Journal of Neural Transmission. 130(11). 1485–1489. 5 indexed citations
8.
Leta, Valentina, Kara Stevens, Angela G. King, et al.. (2023). Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study. PLoS ONE. 18(7). e0285349–e0285349. 2 indexed citations
9.
Jesuthasan, Aaron, et al.. (2021). Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit. Movement Disorders Clinical Practice. 8(4). 541–545. 6 indexed citations
10.
O’Neill, Francis, et al.. (2021). Orofacial pain in 1916 patients with early or moderate Parkinson disease. PAIN Reports. 6(1). e923–e923. 11 indexed citations
11.
Kobylecki, Christopher, et al.. (2021). Falls risk is predictive of dysphagia in Parkinson’s disease. Neurological Sciences. 43(2). 1415–1417. 5 indexed citations
12.
Kobylecki, Christopher. (2020). Update on the diagnosis and management of Parkinson's disease. Clinical Medicine. 20(4). 393–398. 34 indexed citations
13.
Martin, Sarah L., Anthony Jones, Christopher Brown, Christopher Kobylecki, & Monty Silverdale. (2019). A neurophysiological investigation of anticipation to pain in Parkinson's disease. European Journal of Neuroscience. 51(2). 611–627. 9 indexed citations
14.
Jeziorska, Maria, Andrew Atkinson, Lewis Kass‐Iliyya, et al.. (2019). Small Fibre Neuropathy in Parkinson’s Disease: Comparison of Skin Biopsies from the More Affected and Less Affected Sides. Journal of Parkinson s Disease. 9(4). 761–765. 16 indexed citations
15.
Snowden, Julie S., Jennifer Harris, Jennifer A. Saxon, et al.. (2019). Naming and conceptual understanding in frontotemporal dementia. Cortex. 120. 22–35. 19 indexed citations
16.
Henderson, Emily J., et al.. (2019). Management of fracture risk in Parkinson's: A revised algorithm and focused review of treatments. Parkinsonism & Related Disorders. 64. 181–187. 21 indexed citations
17.
Snowden, Julie S., Jennifer Harris, J. C. Thompson, et al.. (2017). Semantic dementia and the left and right temporal lobes. Cortex. 107. 188–203. 86 indexed citations
18.
Kobylecki, Christopher, Alan R. Crossman, & Paula Ravenscroft. (2013). Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia. Experimental Neurology. 247. 476–484. 17 indexed citations
19.
Kobylecki, Christopher, Serena J. Counsell, Nicole Cabanel, et al.. (2013). Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes. Parkinsonism & Related Disorders. 19(5). 527–532. 19 indexed citations
20.
Silverdale, Monty, Christopher Kobylecki, Penelope J. Hallett, et al.. (2009). Synaptic recruitment of AMPA glutamate receptor subunits in levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate. Synapse. 64(2). 177–180. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Pantelyat Breakdown of academic impact, for papers by Maria Pia Giannoccaro Breakdown of academic impact, for papers by Antonella Macerollo Breakdown of academic impact, for papers by Virginia Gao Breakdown of academic impact, for papers by Cesa Scaglione Breakdown of academic impact, for papers by Luisa Sambati Breakdown of academic impact, for papers by Alex Incensi Breakdown of academic impact, for papers by Daniel Bittner Breakdown of academic impact, for papers by Davide Martino Breakdown of academic impact, for papers by Karin Srulijes
Rankless by CCL
2026